opentargets-database

To identify therapeutic drug targets for a specific disease, you can retrieve target-disease associations and supporting genetic evidence directly from the Open Targets Platform using a GraphQL API. This integrates diverse biological and clinical data sources for systematic validation.

You can evaluate a gene's druggability and safety liabilities by querying the Open Targets Platform for target assessment data. The skill retrieves druggability scores, safety profiles, and genetic constraint information to support pharmacology workflows.

Yes, you can retrieve known drug information for drug repurposing via the GraphQL API. The skill facilitates programmatic querying of the Open Targets Platform to identify existing drugs for new indications and supports drug discovery workflows.

Target identification and validation in pharmacology involves finding and confirming potential therapeutic targets for diseases. This skill streamlines the process by providing programmatic access to target-disease associations, genetic evidence, and druggability assessments from the Open Targets Platform.

Yes, you need the requests library to query biomedical data for target discovery. The skill uses it to interact with the Open Targets GraphQL API, enabling systematic retrieval of genetic evidence, druggability assessments, and known drug information.

The best way to gather literature and omics evidence supporting target-disease associations is querying the Open Targets Platform. The skill retrieves detailed evidence including genetics, omics, and literature data via its GraphQL API to validate therapeutic targets.